Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children (Q34452710)

2 August 2017

title

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children (English)

1 reference

attention deficit hyperactivity disorder

2 August 2017

main subject

0 references

1 reference

1

Haiden A Huskamp

1 reference

2 August 2017

Patricia A Deverka

2

1 reference

2 August 2017

Arnold M Epstein

3

1 reference

2 August 2017

Robert S Epstein

4

1 reference

2 August 2017

Kimberly A McGuigan

5

1 reference

2 August 2017

Anna C Muriel

6

1 reference

2 August 2017

Richard G Frank

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

62

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

435-441

1 reference

Pharmacy benefits and the use of drugs by the chronically ill.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

The effect of incentive-based formularies on prescription-drug utilization and spending

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Effect of tiered prescription copayments on the use of preferred brand medications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Employer drug benefit plans and spending on prescription drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Prescription drug prices: why do some pay more than others do?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Health insurance and the demand for medical care: evidence from a randomized experiment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

How do incentive-based formularies influence drug selection and spending for hypertension?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1403292

10.1001/ARCHPSYC.62.4.435

27 October 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference